about
The application of carbon nanotubes in target drug delivery systems for cancer therapiesToxicological considerations when creating nanoparticle-based drugs and drug delivery systemsSurface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer.Nanopharmacology in translational hematology and oncologyCNT Nanobombs for Specific Eradication of Cancer Cells: A New Concept in Cancer Theranostics.Hyaluronic Acid Conjugated Magnetic Prussian Blue@Quantum Dot Nanoparticles for Cancer Theranostics.Immune response in hamsters immunised with a recombinant fragment of LigA from Leptospira interrogans, associated with carrier molecules.Pharmacokinetics, metabolism and toxicity of carbon nanotubes for biomedical purposes.Interactions between proteins and carbon-based nanoparticles: exploring the origin of nanotoxicity at the molecular level.Mechanisms of toxicity by carbon nanotubes.Carbon nanotubes in cancer therapy: a more precise look at the role of carbon nanotube-polymer interactions.Rhamnose-coated superparamagnetic iron-oxide nanoparticles: an evaluation of their in vitro cytotoxicity, genotoxicity and carcinogenicity.Optical Imaging and Gene Therapy with Neuroblastoma-Targeting Polymeric Nanoparticles for Potential Theranostic Applications.Carbon nanotube-reinforced hydroxyapatite composite and their interaction with human osteoblast in vitro.Non-covalent polymer wrapping of carbon nanotubes and the role of wrapped polymers as functional dispersants.Controlling activation barrier by carbon nanotubes as nano-chemical reactors.Does the targeted delivery of theranostic carbon nanotubes have potential as a valid anticancer strategy?Manufacturing Strategy for Multiwalled Carbon Nanotubes as a Biocompatible and Innovative Material
P2860
Q28393485-0F91DF21-7FF9-4B8C-8D93-AEBCFBC42DB6Q28395046-B86A65C6-D179-470E-8519-08F61C8D6D6DQ30439353-1D2986DA-090A-46CB-8E74-A73B05B8E11BQ33961538-3C7B37A7-3B10-407A-8A27-A198C9B8D34AQ34725268-23D4AB2A-06B8-45A0-85E2-08BD96E1F63DQ36296095-B3B86A62-BD0A-4F67-92F6-8AC51C817688Q37444514-343EDEEC-E622-4984-A561-E67B145FBCBAQ38003149-EAF67810-5EDC-4B3A-A8C7-52A00920FB0BQ38049565-14193A66-556E-4EB2-89BD-3A154A6F247FQ38063537-8653A934-9B28-41F6-AFAA-8BDC0C5152BBQ38084838-D56E8349-BD13-4760-884B-39FA4FDAD7DAQ38808707-AD6B3EC9-7D4E-43E6-B0F6-3ECE352900AFQ38819145-894CDE99-FD93-4C20-80DB-E27F80572954Q38955349-66A05B00-2F59-4038-B4B0-24015F59E816Q39017533-5F198E02-D9C3-457F-932E-27F6057C24EFQ46775745-07120C42-599F-43B1-AFEE-2703038CA47AQ51766527-6C268F01-9B86-4F13-BA53-1FE9A880226DQ58910732-C3EC56B2-5950-4A0B-82F1-D216362B84FD
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Carbon nanotubes in cancer theragnosis.
@en
Carbon nanotubes in cancer theragnosis.
@nl
type
label
Carbon nanotubes in cancer theragnosis.
@en
Carbon nanotubes in cancer theragnosis.
@nl
prefLabel
Carbon nanotubes in cancer theragnosis.
@en
Carbon nanotubes in cancer theragnosis.
@nl
P2093
P2860
P356
P1433
P1476
Carbon nanotubes in cancer theragnosis.
@en
P2093
Amit K Jain
Manasmita Das
Swapnil Patil
Vivek S Thakare
P2860
P304
P356
10.2217/NNM.10.95
P50
P577
2010-10-01T00:00:00Z